As Wall Street enters a fourth straight selling week with more Federal Reserve rate hikes to come, many investors are looking to less volatile parts of the market to weather a few months. upcoming gloom. Consumer and investor sentiment remains low, while measures of market volatility have increased in recent weeks. Even some positive economic data appeared to have caused a drop in the stock market, as investors tried to forecast further moves from central banks. “There is a possibility of volatility in the near future,” US Bank Wealth Management’s director of equity strategy, Terry Sandven, said in a note to clients on Tuesday. With that in mind, CNBC Pro started looking for Wall Street favorites with low volatility quality. The stocks below are members of the iShares MSCI USA Min Vol Factor ETF with the highest approval ratings from Wall Street analysts, according to data from FactSet. Source: FactSet The top ranked company on the list is natural gas infrastructure company Cheniere Energy. According to FactSet, the stock has a buy rating from 81% of analysts, even after gaining more than 50% year-to-date. And at least one analyst at one flagship store believes his colleagues are still too optimistic about the company. Morgan Stanley’s Devin McDermott, who has an over-rated rating on the stock, sees Cheniere beating earnings estimates easily through 2024. The stock is on the list with the highest gains relative to its price target. by analyst is Laboratory Corporation of America Holdings with 34.3%. Stocks have struggled this year after rallying strongly in 2020 and 2021, as the Covid pandemic spurred demand for medical testing. Healthcare stocks are also considered defensive stocks and are less volatile than the overall market. UnitedHealth Group and Horizon Therapeutics are two other health names on the list. Other stocks on the list with gains of more than 30% include credit card giants Visa and Mastercard. Both stocks have fallen less than the S&P 500 this year, and they also share a small dividend. While many on Wall Street fear a potential recession, analysts for the credit card companies remain upbeat. Argus analyst Stephen Biggar reiterated his buy rating on Mastercard following the company’s second-quarter earnings report and wrote “we expect spending volumes to continue to improve across most categories. ” – Michael Bloom of CNBC contributed to this report.